Below are the most recent publications written about "Rabies" by people in Profiles.
-
Barn?s-Valldejuly O, Wurzl A, Church B. Clinical Risk Assessment and Treatment of a Man Attacked by a Rabid North American Beaver (Castor canadensis) in the Connecticut River: Case Report. Wilderness Environ Med. 2025 06; 36(2):263-266.
-
Shipley R, Wright E, Smith SP, Selden D, Fooks AR, Banyard AC. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Viruses. 2022 12 09; 14(12).
-
Ejemel M, Smith TG, Greenberg L, Carson WC, Lowe D, Yang Y, Jackson FR, Morgan CN, Martin BE, Kling C, Hutson CL, Gallardo-Romero N, Ellison JA, Moore S, Buzby A, Sullivan-Bolyai J, Klempner M, Wang Y. A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Sci Rep. 2022 06 07; 12(1):9403.
-
Yamada K, Kuribayashi K, Inomata N, Noguchi K, Kimitsuki K, Demetria CS, Saito N, Inoue S, Park CH, Kaimori R, Suzuki M, Saito-Obata M, Kamiya Y, Manalo DL, Quiambao BP, Nishizono A. Validation of serum apolipoprotein A1 in rabies virus-infected mice as a biomarker for the preclinical diagnosis of rabies. Microbiol Immunol. 2021 Oct; 65(10):438-448.
-
Shipley R, Wright E, Lean FZX, Selden D, Horton DL, Fooks AR, Banyard AC. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus. Viruses. 2021 05 20; 13(5).
-
Takahashi T, Inukai M, Sasaki M, Potratz M, Jarusombuti S, Fujii Y, Nishiyama S, Finke S, Yamada K, Sakai H, Sawa H, Nishizono A, Sugiyama M, Ito N. Genetic and Phenotypic Characterization of a Rabies Virus Strain Isolated from a Dog in Tokyo, Japan in the 1940s. Viruses. 2020 08 20; 12(9).
-
Gogtay NJ, Munshi R, Ashwath Narayana DH, Mahendra BJ, Kshirsagar V, Gunale B, Moore S, Cheslock P, Thaker S, Deshpande S, Karande S, Kumbhar D, Ravish HS, Harish BR, Pisal SS, Dhere R, Parulekar V, Blackwelder WC, Molrine DC, Kulkarni PS. Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study. Clin Infect Dis. 2018 01 18; 66(3):387-395.
-
Dolan SB, Jentes ES, Sotir MJ, Han P, Blanton JD, Rao SR, LaRocque RC, Ryan ET, Abraham GM, Alvarez S, Ansdell V, Yates JA, Atkins EH, Cahill J, Birich HK, Vitek D, Connor BA, Dismukes R, Kozarsky P, Dosunmu R, Goad JA, Hagmann S, Hale D, Hynes NA, Jacquerioz F, McLellan S, Knouse M, Lee J, LaRocque RC, Ryan ET, Oladele A, Demeke H, Pasinski R, Wheeler AE, Rao SR, Rosen J, Schwartz BS, Stauffer W, Walker P, Vinetz J. Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium. Vector Borne Zoonotic Dis. 2014 Feb; 14(2):160-7.
-
Gogtay N, Thatte U, Kshirsagar N, Leav B, Molrine D, Cheslock P, Kapre SV, Kulkarni PS. Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults. Vaccine. 2012 Nov 26; 30(50):7315-20.
-
Panning M, Baumgarte S, Pfefferle S, Maier T, Martens A, Drosten C. Comparative analysis of rabies virus reverse transcription-PCR and virus isolation using samples from a patient infected with rabies virus. J Clin Microbiol. 2010 Aug; 48(8):2960-2.